openPR Logo
Press release

Oligonucleotide Therapy Market Key Players Analysis - BPCI Biotech Holding, SomaGenics Inc, Hepion Pharmaceuticals, Alnylam Pharmaceuticals.

12-06-2024 07:22 AM CET | Health & Medicine

Press release from: InsightAce Analytic Pvt. Ltd

Oligonucleotide Therapy Market

Oligonucleotide Therapy Market

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Oligonucleotide Therapy Market - (By Type (Antisense, Ribozymes, Aptamers, miRNA, CpG/Immunostimulatory, RNAi), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others), By End User (Hospitals, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Oligonucleotide Therapy Market is valued at US$ 5.21 Bn in 2023, and it is expected to reach US$ 19.92 Bn by 2031, with a CAGR of 18.6% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2566

Oligonucleotides refer to the short-chain RNA or DNA that are generally manufactured by automated synthesizers. The oligonucleotide is purified using anion exchange chromatography, followed by desalting and freezing. The rising incidence of contagious illnesses such as chickenpox, diphtheria, and the common cold is anticipated to propel the expansion of the oligonucleotides market during the projected timeframe. In addition, the development of more stable and prolonged half-life molecules due to the advancement of technologies and the upgradation of chemically synthesized oligonucleotides which is anticipated to boost the growth of the oligonucleotides market at a significant rate over the forecast period. Furthermore, an increasing number of mergers, acquisitions, and product launches among the manufacturers and market players to provide medical care to patients are expected to result in the expansion of the oligonucleotide therapy market.

List of Prominent Players in the Oligonucleotide Therapy Market:
• BPCI Biotech Holding
• SomaGenics Inc
• Hepion Pharmaceuticals
• Alnylam Pharmaceuticals
• Regulus Therapeutics Inc
• Ionis Pharmaceuticals
• Gilead Sciences, Inc
• Santaris
• InteRNA Technologies B.V.
• Mirage
• Biogen
• Merck KgaA
• Pfizer Inc.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Market Dynamics:
Drivers-
Advancements in biotechnology and the pharmaceutical industry are driving the increasing use of synthesized oligos in therapeutic applications. Rising government investments in synthetic biology and genome projects are fueling research and development efforts in oligonucleotide therapeutics, leading to innovative treatments and technologies. Moreover, the growing focus on personalized medicine is shaping the oligonucleotide therapeutics market by tailoring treatments to individual patients based on genetic profiles and specific medical needs. These key drivers are propelling the market towards precision medicine, improved patient outcomes, and the development of targeted therapies for various diseases.

Challenges:
The inability to detect minor antibodies could hinder market growth by impacting the efficacy and safety of oligonucleotide therapies. This limitation may lead to uncertainties in treatment outcomes and patient responses. Additionally, stringent regulations pose challenges by increasing the complexity and cost of development, approval, and commercialization processes for oligonucleotide therapeutics. Overcoming these obstacles will require advancements in detection technologies, robust clinical data, and strategic compliance measures to navigate regulatory requirements and drive market success. Another challenge is the high cost and complexities of Oligonucleotide Therapy, which is hindering market growth.

Regional Trends:
The North American oligonucleotide Therapy Market is expected to register a maximum market revenue share and it is projected to grow at a high CAGR in the near future. Anticipated revenue growth is expected to be driven by the expansion of oligonucleotide therapies targeting disorders such as cancer and neurological conditions. Besides, Europe had a remarkable share in the market due to increasing demand for custom oligonucleotides in research, diagnostics, and therapeutics. Factors like advancements in synthetic biology, rising applications in precision medicine, and expanding biotechnology and pharmaceutical industries contribute to its expansion.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2566

Recent Developments:
• In May 2023, Chinook Therapeutics and Ionis Pharmaceuticals have partnered to jointly research, develop, and market an antisense oligonucleotide therapeutic aimed at treating a rare and severe chronic kidney disease.
• In March 2023, AusperBio has reported the successful administration of the first dose of AHB-137, an antisense oligonucleotide therapeutic candidate, to a human subject for the treatment of chronic Hepatitis B.

Segmentation of Oligonucleotide Therapy Market-
By Type-
• Antisense
• Ribozymes
• Aptamers
• Mirna
• CpG/Immunostimulatory
• RNAi
By Application-
• Infectious Diseases
• Oncology
• Neurodegenerative Disorders
• Cardiovascular Diseases
• Kidney Diseases
• Others
By End-User-
• Hospitals
• Research Institutes
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2566

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oligonucleotide Therapy Market Key Players Analysis - BPCI Biotech Holding, SomaGenics Inc, Hepion Pharmaceuticals, Alnylam Pharmaceuticals. here

News-ID: 3775147 • Views:

More Releases from InsightAce Analytic Pvt. Ltd

Biocides Market Latest Trends and Growth Factors Analysis 2024 to 2031
Biocides Market Latest Trends and Growth Factors Analysis 2024 to 2031
"Biocides Market" in terms of revenue was estimated to be worth $11.57 billion in 2023 and is poised to reach $16.83 billion by 2031, growing at a CAGR of 4.91% from 2024 to 2031, according to a new report by InsightAce Analytic. Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1637 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global Biocides Market are: • Growing Awareness of Hygiene and
Beneficial Insects Market Current Scenario with Future Trends Analysis to 2031
Beneficial Insects Market Current Scenario with Future Trends Analysis to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Beneficial Insects Market Size, Share & Trends Analysis Report By Application (Crop protection, Crop production), Type (Predators, Parasitoids, Pathogens, and Pollinators), Crop Type (Fruits & Vegetables, Flowers & Ornamentals, and Grains & Pulses), Region, Market Outlook And Industry Analysis 2031" The global Beneficial Insects market is estimated to reach over USD 2.18 billion by 2031, exhibiting
Avocado Puree Market Current Scenario with Future Trends Analysis to 2031
Avocado Puree Market Current Scenario with Future Trends Analysis to 2031
The global avocado puree market is estimated to reach over USD 755.03 million by 2031, exhibiting a CAGR of 5.18% during the forecast period. Fresh avocados mashed, puréed, pressed, or sieved into a creamy slurry or paste consistency are used to make avocado purees. Avocado purees make mixed fruit drinks, infant food, and guacamole. Avocado puree market revenue is predicted to increase at a high CAGR, driven by millennials' phenomenal demand
Automotive Lead Acid Battery Market Latest Trends and Growth Factors Analysis 2024 to 2031
Automotive Lead Acid Battery Market Latest Trends and Growth Factors Analysis 20 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Automotive Lead Acid Battery Market Size, Share & Trends Analysis Report By Product (SLI and Micro-Hybrid Batteries), Type (Flooded, Enhanced Flooded, and VRLA), Customer Segment (OEM and Aftermarket), End User (Passenger Car, Light Commercial Vehicles, Heavy Commercial Vehicles, Two-Wheeler, and Three-Wheeler), and Application (Hybrid Vehicles, Electric Vehicles, Light Motor Vehicles, and Heavy Motor Vehicles)- Market

All 5 Releases


More Releases for Oligonucleotide

Oligonucleotide Synthesis Market Size and Share 2022-2027
According to IMARC Group's latest report, titled "Oligonucleotide Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global oligonucleotide synthesis market reached a value of US$ 2.4 Billion in 2021. Oligonucleotide synthesis is the chemical synthesis of little fragments of nucleic acids that are produced through enzymatic chemistry and genetic engineering. It is used in laboratories for diagnostics, academic, industrial, and therapeutic applications. Oligonucleotide synthesis helps in building
Oligonucleotide Synthesis Market Growing with Rising Cancer Burden
The most-prominent factors leading to the growth of the oligonucleotide synthesis market are the technological advancements in the field, increasing government support, rising number of research studies related to synthetic biology, and surging incidence of infections and cancer. As a result, the worth of the sales of synthesized oligonucleotides will increase from $1.5 billion in 2017 to $2.8 billion by 2023, at a 10.8% CAGR during the forecast period (2018–2023).
Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthes …
Researchmoz added latest report "Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthesis Service Type Segment to Hold 70% Market Share by 2025". The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. Our new research report on the global oligonucleotide synthesis market gives a brief overview of the global market. The report includes projections on the global oligonucleotide synthesis
Oligonucleotide Synthesis: Custom Oligonucleotide Synthesis Service Type Segment …
Research Report on "Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthesis Service Type Segment to Hold 70% Market Share by 2025". Our new research report on the global oligonucleotide synthesis market gives a brief overview of the global market. The report includes projections on the global oligonucleotide synthesis market revenue growth and the factors likely to impact this growth during the period of forecast. The report describes the scenario of
Global Oligonucleotide Market Research Report Forecast 2017-2021
The report, titled Global Oligonucleotide Market 2017 is a methodical research study based on the Oligonucleotide market, analyzing the competitive framework of the industry in the world. Using efficient analytical tools such as SWOT analysis and Porter’s five forces analysis, the report provides a comprehensive assessment of the Oligonucleotide market. The report estimates the market size in terms of volume (kilo tons) and revenue (US$) produced, whereas, the key segments and
Oligonucleotide Synthesis Market 2017 Development Trends
This report studies the global Oligonucleotide Synthesis market, analyzes and researches the Oligonucleotide Synthesis development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Agilent Technologies Biosearch Technologies Eurofins Genomics Eurogentec Integrated DNA Technologies Merck KGAA Thermo Fisher Scientific GeneDesign Bio-Synthesis - CRO/CMO Life Sciences Company Bioautomation GE Healthcare LGC Biosearch Technologies NITTO Denko Avecia For more information about this report at http://www.reportsweb.com/global-oligonucleotide-synthesis-market-size-status-and-forecast-2022 Market segment by Regions/Countries, this report